Caraco Pharma announces FDA approval to market methimazole tablets USP, 5 mg and 10 mg

Wed Sep 26, 2007 10:02am EDT

Co announces the FDA has granted final approval for the co's Abbreviated New Drug Application for Methimazole Tablets USP, 5 mg and 10 mg. The co's Methimazole is therapeutically equivalent to the FDA reference listed drug listed in the Orange Book, Methimazole Tablets USP, 5 mg and 10 mg, respectively. According to IMS Data, for the twelve months ended June 2007, Methimazole had annual sales of approx $21 mln. 

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.